These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 37169888)

  • 21. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity.
    Shakhpazyan NK; Mikhaleva LM; Bedzhanyan AL; Gioeva ZV; Mikhalev AI; Midiber KY; Pechnikova VV; Biryukov AE
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention.
    Pandey M; Bhattacharyya J
    Epigenomics; 2024 Mar; 16(6):403-418. PubMed ID: 38410915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinogenesis and Gut Microbiota].
    Shiotani A; Fukushima S; Matsumoto H
    Gan To Kagaku Ryoho; 2019 Feb; 46(2):199-204. PubMed ID: 30914517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer.
    El Tekle G; Andreeva N; Garrett WS
    Annu Rev Physiol; 2024 Feb; 86():453-478. PubMed ID: 38345904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer.
    Privitera G; Rana N; Scaldaferri F; Armuzzi A; Pizarro TT
    Front Cell Infect Microbiol; 2021; 11():806680. PubMed ID: 35111698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota.
    Loke YL; Chew MT; Ngeow YF; Lim WWD; Peh SC
    Front Cell Infect Microbiol; 2020; 10():603086. PubMed ID: 33364203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gut microbiota on colorectal cancer progression and treatment.
    Alasiri GA
    Saudi Med J; 2022 Dec; 43(12):1289-1299. PubMed ID: 36517053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbe-based therapies for colorectal cancer: Advantages and limitations.
    Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise-induced changes to the human gut microbiota and implications for colorectal cancer: a narrative review.
    Boytar AN; Nitert MD; Morrision M; Skinner TL; Jenkins DG
    J Physiol; 2022 Dec; 600(24):5189-5201. PubMed ID: 36369926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of the intratumoral microbiota in colorectal cancer immunotherapy.
    Fan S; Zhang W; Zhou L; Wang D; Tang D
    Int Immunopharmacol; 2024 Aug; 137():112537. PubMed ID: 38909493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player?
    Patel M; McAllister M; Nagaraju R; Badran SSFA; Edwards J; McBain AJ; Barriuso J; Aziz O
    Crit Rev Oncol Hematol; 2022 Dec; 180():103856. PubMed ID: 36257533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota-derived metabolites in CRC progression and causation.
    Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.